Katja Rosenkranz

Director/Miembro de la Junta en

Dualyx NV

Finance

Health Technology

Commercial Services

Perfil

Katja Rosenkranz is currently the Director at dualyx NV since 2020 and a Partner at V-Bio Ventures BV since 2016.
Previously, she worked as the Director-Executive Board at Clearstream Banking AG from 2009 to 2012.
She also held positions as Director at AgomAb Therapeutics NV and COO, CFO & Head-Administration at Advitos GmbH from 2009 to 2012.

Cargos activos de Katja Rosenkranz

Empresas	Cargo	Inicio
V-Bio Ventures BV V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures invests in companies located in Europe and beyond. The firm focuses on sectors such as therapeutics, including both drug discovery and drug development. It participates in early stage capital requirements.	Inversor de Capital Privado	01/01/2016
Dualyx NV Dualyx NV Miscellaneous Commercial ServicesCommercial Services Develops differentiated biologicals for autoimmune diseases	Director/Miembro de la Junta	31/05/2020

Todos los cargos activos de Katja Rosenkranz

Antiguos cargos conocidos de Katja Rosenkranz.

Empresas	Cargo	Fin
Clearstream Banking AG Clearstream Banking AG Regional BanksFinance Provides commercial banking services	Corporate Officer/Principal	31/03/2012
AGOMAB THERAPEUTICS NV	Director/Miembro de la Junta	-
Advitos GmbH Advitos GmbH Medical SpecialtiesHealth Technology Develops and commercializes liver support therapy devices	Director Financiero/CFO	14/06/2012

Ver el detalle de la experiencia de Katja Rosenkranz.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Katja Rosenkranz.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
Clearstream Banking AG Clearstream Banking AG Regional BanksFinance Provides commercial banking services	Finance
Advitos GmbH Advitos GmbH Medical SpecialtiesHealth Technology Develops and commercializes liver support therapy devices	Health Technology
V-Bio Ventures BV V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures invests in companies located in Europe and beyond. The firm focuses on sectors such as therapeutics, including both drug discovery and drug development. It participates in early stage capital requirements.	Finance
AgomAb Therapeutics NV AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues	Health Technology
Dualyx NV Dualyx NV Miscellaneous Commercial ServicesCommercial Services Develops differentiated biologicals for autoimmune diseases	Commercial Services